tiprankstipranks
Trending News
More News >
Ars Pharmaceuticals, Inc. (SPRY)
:SPRY
US Market

ARS Pharmaceuticals (SPRY) Balance Sheet

Compare
538 Followers

ARS Pharmaceuticals Balance Sheet

ARS Pharmaceuticals's total assets for Q3 2025 were $372.80M, a decrease of ― from the previous quarter. SPRY total liabilities were $225.15M for the fiscal quarter, a ― a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.
Balance Sheet
Dec 24Dec 23Dec 22Dec 21Dec 20
Total Assets
$ 351.15M$ 233.19M$ 281.44M$ 61.45M$ 26.41M
Total Liabilities
$ 94.36M$ 2.43M$ 8.55M$ 92.72M$ 40.46M
Total Equity Gross Minority
$ 256.80M$ 230.76M$ 272.89M$ -31.27M$ -14.05M
Other Metrics
Currency in USD

ARS Pharmaceuticals Debt to Assets